Joshua Meeks, Urologic Oncologist and Scientist at Northwestern University, shared a post on X:
“Very excited for bioRxiv on multi-omic (RNA-seq, targeted mutations, single-cell, spatial) T1 analysis for BCG response.
Genomic and transcriptomic profiling of high-risk bladder cancer reveals diverse molecular and microenvironment ecosystems.”
Authors: Khyati Meghani, Yanni Yu, Noahh Frydenlund, Erik Z Li, Bonnie Choy, Sarki Abdulkadir, Joshua J Meek
